1 Market Overview

1.1 Product Overview and Scope of Antibody Drug Conjugate (ADC) Drug

1.2 Classification of Antibody Drug Conjugate (ADC) Drug by Type

1.2.1 Overview: Global Antibody Drug Conjugate (ADC) Drug Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Antibody Drug Conjugate (ADC) Drug Revenue Market Share by Type in 2020

1.2.3 Mmunomedics Technology

1.2.4 Immunogen Technology

1.2.5 Seattle Genetics Technology

1.2.6 Others

1.3 Global Antibody Drug Conjugate (ADC) Drug Market by Application

1.3.1 Overview: Global Antibody Drug Conjugate (ADC) Drug Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Biotechnology Companies

1.3.3 Specialized Cancer Centers

1.3.4 Biopharmaceutical Companies

1.3.5 Academic Research Institutes

1.3.6 Hospitals

1.3.7 Others

1.4 Global Antibody Drug Conjugate (ADC) Drug Market Size & Forecast

1.5 Global Antibody Drug Conjugate (ADC) Drug Market Size and Forecast by Region

1.5.1 Global Antibody Drug Conjugate (ADC) Drug Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Antibody Drug Conjugate (ADC) Drug Market Size by Region, (2016-2021)

1.5.3 North America Antibody Drug Conjugate (ADC) Drug Market Size and Prospect (2016-2026)

1.5.4 Europe Antibody Drug Conjugate (ADC) Drug Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Antibody Drug Conjugate (ADC) Drug Market Size and Prospect (2016-2026)

1.5.6 South America Antibody Drug Conjugate (ADC) Drug Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Antibody Drug Conjugate (ADC) Drug Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Antibody Drug Conjugate (ADC) Drug Market Drivers

1.6.2 Antibody Drug Conjugate (ADC) Drug Market Restraints

1.6.3 Antibody Drug Conjugate (ADC) Drug Trends Analysis

2 Company Profiles

2.1 Oxford Bio Therapeutics

2.1.1 Oxford Bio Therapeutics Details

2.1.2 Oxford Bio Therapeutics Major Business

2.1.3 Oxford Bio Therapeutics Antibody Drug Conjugate (ADC) Drug Product and Solutions

2.1.4 Oxford Bio Therapeutics Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 Oxford Bio Therapeutics Recent Developments and Future Plans

2.2 Synthon

2.2.1 Synthon Details

2.2.2 Synthon Major Business

2.2.3 Synthon Antibody Drug Conjugate (ADC) Drug Product and Solutions

2.2.4 Synthon Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Synthon Recent Developments and Future Plans

2.3 Progenics Pharmaceuticals

2.3.1 Progenics Pharmaceuticals Details

2.3.2 Progenics Pharmaceuticals Major Business

2.3.3 Progenics Pharmaceuticals Antibody Drug Conjugate (ADC) Drug Product and Solutions

2.3.4 Progenics Pharmaceuticals Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Progenics Pharmaceuticals Recent Developments and Future Plans

2.4 Bayer HealthCare

2.4.1 Bayer HealthCare Details

2.4.2 Bayer HealthCare Major Business

2.4.3 Bayer HealthCare Antibody Drug Conjugate (ADC) Drug Product and Solutions

2.4.4 Bayer HealthCare Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Bayer HealthCare Recent Developments and Future Plans

2.5 Millennium Pharmaceuticals

2.5.1 Millennium Pharmaceuticals Details

2.5.2 Millennium Pharmaceuticals Major Business

2.5.3 Millennium Pharmaceuticals Antibody Drug Conjugate (ADC) Drug Product and Solutions

2.5.4 Millennium Pharmaceuticals Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 Millennium Pharmaceuticals Recent Developments and Future Plans

2.6 Pfizer

2.6.1 Pfizer Details

2.6.2 Pfizer Major Business

2.6.3 Pfizer Antibody Drug Conjugate (ADC) Drug Product and Solutions

2.6.4 Pfizer Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 Pfizer Recent Developments and Future Plans

2.7 Concortis Bio therapeutics

2.7.1 Concortis Bio therapeutics Details

2.7.2 Concortis Bio therapeutics Major Business

2.7.3 Concortis Bio therapeutics Antibody Drug Conjugate (ADC) Drug Product and Solutions

2.7.4 Concortis Bio therapeutics Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 Concortis Bio therapeutics Recent Developments and Future Plans

2.8 Roche Holding AG

2.8.1 Roche Holding AG Details

2.8.2 Roche Holding AG Major Business

2.8.3 Roche Holding AG Antibody Drug Conjugate (ADC) Drug Product and Solutions

2.8.4 Roche Holding AG Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 Roche Holding AG Recent Developments and Future Plans

2.9 Seattle Genetics

2.9.1 Seattle Genetics Details

2.9.2 Seattle Genetics Major Business

2.9.3 Seattle Genetics Antibody Drug Conjugate (ADC) Drug Product and Solutions

2.9.4 Seattle Genetics Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 Seattle Genetics Recent Developments and Future Plans

2.10 Heidelberg Pharma

2.10.1 Heidelberg Pharma Details

2.10.2 Heidelberg Pharma Major Business

2.10.3 Heidelberg Pharma Antibody Drug Conjugate (ADC) Drug Product and Solutions

2.10.4 Heidelberg Pharma Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 Heidelberg Pharma Recent Developments and Future Plans

2.11 Mersana Therapeutics

2.11.1 Mersana Therapeutics Details

2.11.2 Mersana Therapeutics Major Business

2.11.3 Mersana Therapeutics Antibody Drug Conjugate (ADC) Drug Product and Solutions

2.11.4 Mersana Therapeutics Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2019-2021)

2.11.5 Mersana Therapeutics Recent Developments and Future Plans

2.12 Astellas Pharma/Agensys

2.12.1 Astellas Pharma/Agensys Details

2.12.2 Astellas Pharma/Agensys Major Business

2.12.3 Astellas Pharma/Agensys Antibody Drug Conjugate (ADC) Drug Product and Solutions

2.12.4 Astellas Pharma/Agensys Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2019-2021)

2.12.5 Astellas Pharma/Agensys Recent Developments and Future Plans

2.13 AbbVie Inc

2.13.1 AbbVie Inc Details

2.13.2 AbbVie Inc Major Business

2.13.3 AbbVie Inc Antibody Drug Conjugate (ADC) Drug Product and Solutions

2.13.4 AbbVie Inc Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2019-2021)

2.13.5 AbbVie Inc Recent Developments and Future Plans

2.14 Celldex Therapeutics

2.14.1 Celldex Therapeutics Details

2.14.2 Celldex Therapeutics Major Business

2.14.3 Celldex Therapeutics Antibody Drug Conjugate (ADC) Drug Product and Solutions

2.14.4 Celldex Therapeutics Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2019-2021)

2.14.5 Celldex Therapeutics Recent Developments and Future Plans

2.15 Immunomedics

2.15.1 Immunomedics Details

2.15.2 Immunomedics Major Business

2.15.3 Immunomedics Antibody Drug Conjugate (ADC) Drug Product and Solutions

2.15.4 Immunomedics Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2019-2021)

2.15.5 Immunomedics Recent Developments and Future Plans

2.16 Agensys

2.16.1 Agensys Details

2.16.2 Agensys Major Business

2.16.3 Agensys Antibody Drug Conjugate (ADC) Drug Product and Solutions

2.16.4 Agensys Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2019-2021)

2.16.5 Agensys Recent Developments and Future Plans

2.17 Genentech

2.17.1 Genentech Details

2.17.2 Genentech Major Business

2.17.3 Genentech Antibody Drug Conjugate (ADC) Drug Product and Solutions

2.17.4 Genentech Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2019-2021)

2.17.5 Genentech Recent Developments and Future Plans

2.18 ImmunoGen

2.18.1 ImmunoGen Details

2.18.2 ImmunoGen Major Business

2.18.3 ImmunoGen Antibody Drug Conjugate (ADC) Drug Product and Solutions

2.18.4 ImmunoGen Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2019-2021)

2.18.5 ImmunoGen Recent Developments and Future Plans

2.19 Sanofi

2.19.1 Sanofi Details

2.19.2 Sanofi Major Business

2.19.3 Sanofi Antibody Drug Conjugate (ADC) Drug Product and Solutions

2.19.4 Sanofi Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2019-2021)

2.19.5 Sanofi Recent Developments and Future Plans

2.20 Genmab

2.20.1 Genmab Details

2.20.2 Genmab Major Business

2.20.3 Genmab Antibody Drug Conjugate (ADC) Drug Product and Solutions

2.20.4 Genmab Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2019-2021)

2.20.5 Genmab Recent Developments and Future Plans

2.21 Amgen

2.21.1 Amgen Details

2.21.2 Amgen Major Business

2.21.3 Amgen Antibody Drug Conjugate (ADC) Drug Product and Solutions

2.21.4 Amgen Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2019-2021)

2.21.5 Amgen Recent Developments and Future Plans

2.22 Novartis

2.22.1 Novartis Details

2.22.2 Novartis Major Business

2.22.3 Novartis Antibody Drug Conjugate (ADC) Drug Product and Solutions

2.22.4 Novartis Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2019-2021)

2.22.5 Novartis Recent Developments and Future Plans

2.23 Eli Lilly

2.23.1 Eli Lilly Details

2.23.2 Eli Lilly Major Business

2.23.3 Eli Lilly Antibody Drug Conjugate (ADC) Drug Product and Solutions

2.23.4 Eli Lilly Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2019-2021)

2.23.5 Eli Lilly Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Antibody Drug Conjugate (ADC) Drug Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Antibody Drug Conjugate (ADC) Drug Players Market Share

3.2.2 Top 10 Antibody Drug Conjugate (ADC) Drug Players Market Share

3.2.3 Market Competition Trend

3.3 Antibody Drug Conjugate (ADC) Drug Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Antibody Drug Conjugate (ADC) Drug Revenue and Market Share by Type (2016-2021)

4.2 Global Antibody Drug Conjugate (ADC) Drug Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Antibody Drug Conjugate (ADC) Drug Revenue Market Share by Application (2016-2021)

5.2 Antibody Drug Conjugate (ADC) Drug Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Antibody Drug Conjugate (ADC) Drug Revenue by Type (2016-2026)

6.2 North America Antibody Drug Conjugate (ADC) Drug Revenue by Application (2016-2026)

6.3 North America Antibody Drug Conjugate (ADC) Drug Market Size by Country

6.3.1 North America Antibody Drug Conjugate (ADC) Drug Revenue by Country (2016-2026)

6.3.2 United States Antibody Drug Conjugate (ADC) Drug Market Size and Forecast (2016-2026)

6.3.3 Canada Antibody Drug Conjugate (ADC) Drug Market Size and Forecast (2016-2026)

6.3.4 Mexico Antibody Drug Conjugate (ADC) Drug Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Antibody Drug Conjugate (ADC) Drug Revenue by Type (2016-2026)

7.2 Europe Antibody Drug Conjugate (ADC) Drug Revenue by Application (2016-2026)

7.3 Europe Antibody Drug Conjugate (ADC) Drug Market Size by Country

7.3.1 Europe Antibody Drug Conjugate (ADC) Drug Revenue by Country (2016-2026)

7.3.2 Germany Antibody Drug Conjugate (ADC) Drug Market Size and Forecast (2016-2026)

7.3.3 France Antibody Drug Conjugate (ADC) Drug Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Antibody Drug Conjugate (ADC) Drug Market Size and Forecast (2016-2026)

7.3.5 Russia Antibody Drug Conjugate (ADC) Drug Market Size and Forecast (2016-2026)

7.3.6 Italy Antibody Drug Conjugate (ADC) Drug Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Antibody Drug Conjugate (ADC) Drug Revenue by Type (2016-2026)

8.2 Asia-Pacific Antibody Drug Conjugate (ADC) Drug Revenue by Application (2016-2026)

8.3 Asia-Pacific Antibody Drug Conjugate (ADC) Drug Market Size by Region

8.3.1 Asia-Pacific Antibody Drug Conjugate (ADC) Drug Revenue by Region (2016-2026)

8.3.2 China Antibody Drug Conjugate (ADC) Drug Market Size and Forecast (2016-2026)

8.3.3 Japan Antibody Drug Conjugate (ADC) Drug Market Size and Forecast (2016-2026)

8.3.4 South Korea Antibody Drug Conjugate (ADC) Drug Market Size and Forecast (2016-2026)

8.3.5 India Antibody Drug Conjugate (ADC) Drug Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Antibody Drug Conjugate (ADC) Drug Market Size and Forecast (2016-2026)

8.3.7 Australia Antibody Drug Conjugate (ADC) Drug Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Antibody Drug Conjugate (ADC) Drug Revenue by Type (2016-2026)

9.2 South America Antibody Drug Conjugate (ADC) Drug Revenue by Application (2016-2026)

9.3 South America Antibody Drug Conjugate (ADC) Drug Market Size by Country

9.3.1 South America Antibody Drug Conjugate (ADC) Drug Revenue by Country (2016-2026)

9.3.2 Brazil Antibody Drug Conjugate (ADC) Drug Market Size and Forecast (2016-2026)

9.3.3 Argentina Antibody Drug Conjugate (ADC) Drug Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Antibody Drug Conjugate (ADC) Drug Revenue by Type (2016-2026)

10.2 Middle East & Africa Antibody Drug Conjugate (ADC) Drug Revenue by Application (2016-2026)

10.3 Middle East & Africa Antibody Drug Conjugate (ADC) Drug Market Size by Country

10.3.1 Middle East & Africa Antibody Drug Conjugate (ADC) Drug Revenue by Country (2016-2026)

10.3.2 Turkey Antibody Drug Conjugate (ADC) Drug Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Antibody Drug Conjugate (ADC) Drug Market Size and Forecast (2016-2026)

10.3.4 UAE Antibody Drug Conjugate (ADC) Drug Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Antibody Drug Conjugate (ADC) Drug Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Antibody Drug Conjugate (ADC) Drug Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Antibody Drug Conjugate (ADC) Drug Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Antibody Drug Conjugate (ADC) Drug Revenue (USD Million) by Region (2016-2021)

Table 5. Global Antibody Drug Conjugate (ADC) Drug Revenue Market Share by Region (2021-2026)

Table 6. Oxford Bio Therapeutics Corporate Information, Head Office, and Major Competitors

Table 7. Oxford Bio Therapeutics Major Business

Table 8. Oxford Bio Therapeutics Antibody Drug Conjugate (ADC) Drug Product and Solutions

Table 9. Oxford Bio Therapeutics Antibody Drug Conjugate (ADC) Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Synthon Corporate Information, Head Office, and Major Competitors

Table 11. Synthon Major Business

Table 12. Synthon Antibody Drug Conjugate (ADC) Drug Product and Solutions

Table 13. Synthon Antibody Drug Conjugate (ADC) Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. Progenics Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 15. Progenics Pharmaceuticals Major Business

Table 16. Progenics Pharmaceuticals Antibody Drug Conjugate (ADC) Drug Product and Solutions

Table 17. Progenics Pharmaceuticals Antibody Drug Conjugate (ADC) Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. Bayer HealthCare Corporate Information, Head Office, and Major Competitors

Table 19. Bayer HealthCare Major Business

Table 20. Bayer HealthCare Antibody Drug Conjugate (ADC) Drug Product and Solutions

Table 21. Bayer HealthCare Antibody Drug Conjugate (ADC) Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. Millennium Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 23. Millennium Pharmaceuticals Major Business

Table 24. Millennium Pharmaceuticals Antibody Drug Conjugate (ADC) Drug Product and Solutions

Table 25. Millennium Pharmaceuticals Antibody Drug Conjugate (ADC) Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. Pfizer Corporate Information, Head Office, and Major Competitors

Table 27. Pfizer Major Business

Table 28. Pfizer Antibody Drug Conjugate (ADC) Drug Product and Solutions

Table 29. Pfizer Antibody Drug Conjugate (ADC) Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. Concortis Bio therapeutics Corporate Information, Head Office, and Major Competitors

Table 31. Concortis Bio therapeutics Major Business

Table 32. Concortis Bio therapeutics Antibody Drug Conjugate (ADC) Drug Product and Solutions

Table 33. Concortis Bio therapeutics Antibody Drug Conjugate (ADC) Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. Roche Holding AG Corporate Information, Head Office, and Major Competitors

Table 35. Roche Holding AG Major Business

Table 36. Roche Holding AG Antibody Drug Conjugate (ADC) Drug Product and Solutions

Table 37. Roche Holding AG Antibody Drug Conjugate (ADC) Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. Seattle Genetics Corporate Information, Head Office, and Major Competitors

Table 39. Seattle Genetics Major Business

Table 40. Seattle Genetics Antibody Drug Conjugate (ADC) Drug Product and Solutions

Table 41. Seattle Genetics Antibody Drug Conjugate (ADC) Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. Heidelberg Pharma Corporate Information, Head Office, and Major Competitors

Table 43. Heidelberg Pharma Major Business

Table 44. Heidelberg Pharma Antibody Drug Conjugate (ADC) Drug Product and Solutions

Table 45. Heidelberg Pharma Antibody Drug Conjugate (ADC) Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. Mersana Therapeutics Corporate Information, Head Office, and Major Competitors

Table 47. Mersana Therapeutics Major Business

Table 48. Mersana Therapeutics Antibody Drug Conjugate (ADC) Drug Product and Solutions

Table 49. Mersana Therapeutics Antibody Drug Conjugate (ADC) Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 50. Astellas Pharma/Agensys Corporate Information, Head Office, and Major Competitors

Table 51. Astellas Pharma/Agensys Major Business

Table 52. Astellas Pharma/Agensys Antibody Drug Conjugate (ADC) Drug Product and Solutions

Table 53. Astellas Pharma/Agensys Antibody Drug Conjugate (ADC) Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 54. AbbVie Inc Corporate Information, Head Office, and Major Competitors

Table 55. AbbVie Inc Major Business

Table 56. AbbVie Inc Antibody Drug Conjugate (ADC) Drug Product and Solutions

Table 57. AbbVie Inc Antibody Drug Conjugate (ADC) Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 58. Celldex Therapeutics Corporate Information, Head Office, and Major Competitors

Table 59. Celldex Therapeutics Major Business

Table 60. Celldex Therapeutics Antibody Drug Conjugate (ADC) Drug Product and Solutions

Table 61. Celldex Therapeutics Antibody Drug Conjugate (ADC) Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 62. Immunomedics Corporate Information, Head Office, and Major Competitors

Table 63. Immunomedics Major Business

Table 64. Immunomedics Antibody Drug Conjugate (ADC) Drug Product and Solutions

Table 65. Immunomedics Antibody Drug Conjugate (ADC) Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 66. Agensys Corporate Information, Head Office, and Major Competitors

Table 67. Agensys Major Business

Table 68. Agensys Antibody Drug Conjugate (ADC) Drug Product and Solutions

Table 69. Agensys Antibody Drug Conjugate (ADC) Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 70. Genentech Corporate Information, Head Office, and Major Competitors

Table 71. Genentech Major Business

Table 72. Genentech Antibody Drug Conjugate (ADC) Drug Product and Solutions

Table 73. Genentech Antibody Drug Conjugate (ADC) Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 74. ImmunoGen Corporate Information, Head Office, and Major Competitors

Table 75. ImmunoGen Major Business

Table 76. ImmunoGen Antibody Drug Conjugate (ADC) Drug Product and Solutions

Table 77. ImmunoGen Antibody Drug Conjugate (ADC) Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 78. Sanofi Corporate Information, Head Office, and Major Competitors

Table 79. Sanofi Major Business

Table 80. Sanofi Antibody Drug Conjugate (ADC) Drug Product and Solutions

Table 81. Sanofi Antibody Drug Conjugate (ADC) Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 82. Genmab Corporate Information, Head Office, and Major Competitors

Table 83. Genmab Major Business

Table 84. Genmab Antibody Drug Conjugate (ADC) Drug Product and Solutions

Table 85. Genmab Antibody Drug Conjugate (ADC) Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 86. Amgen Corporate Information, Head Office, and Major Competitors

Table 87. Amgen Major Business

Table 88. Amgen Antibody Drug Conjugate (ADC) Drug Product and Solutions

Table 89. Amgen Antibody Drug Conjugate (ADC) Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 90. Novartis Corporate Information, Head Office, and Major Competitors

Table 91. Novartis Major Business

Table 92. Novartis Antibody Drug Conjugate (ADC) Drug Product and Solutions

Table 93. Novartis Antibody Drug Conjugate (ADC) Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 94. Eli Lilly Corporate Information, Head Office, and Major Competitors

Table 95. Eli Lilly Major Business

Table 96. Eli Lilly Antibody Drug Conjugate (ADC) Drug Product and Solutions

Table 97. Eli Lilly Antibody Drug Conjugate (ADC) Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 98. Global Antibody Drug Conjugate (ADC) Drug Revenue (USD Million) by Players (2019-2021)

Table 99. Global Antibody Drug Conjugate (ADC) Drug Revenue Share by Players (2019-2021)

Table 100. Breakdown of Antibody Drug Conjugate (ADC) Drug by Company Type (Tier 1, Tier 2 and Tier 3)

Table 101. Antibody Drug Conjugate (ADC) Drug Players Head Office, Products and Services Provided

Table 102. Antibody Drug Conjugate (ADC) Drug Mergers & Acquisitions in the Past Five Years

Table 103. Antibody Drug Conjugate (ADC) Drug New Entrants and Expansion Plans

Table 104. Global Antibody Drug Conjugate (ADC) Drug Revenue (USD Million) by Type (2016-2021)

Table 105. Global Antibody Drug Conjugate (ADC) Drug Revenue Share by Type (2016-2021)

Table 106. Global Antibody Drug Conjugate (ADC) Drug Revenue Forecast by Type (2021-2026)

Table 107. Global Antibody Drug Conjugate (ADC) Drug Revenue by Application (2016-2021)

Table 108. Global Antibody Drug Conjugate (ADC) Drug Revenue Forecast by Application (2021-2026)

Table 109. North America Antibody Drug Conjugate (ADC) Drug Revenue by Type (2016-2021) & (USD Million)

Table 110. North America Antibody Drug Conjugate (ADC) Drug Revenue by Type (2021-2026) & (USD Million)

Table 111. North America Antibody Drug Conjugate (ADC) Drug Revenue by Application (2016-2021) & (USD Million)

Table 112. North America Antibody Drug Conjugate (ADC) Drug Revenue by Application (2021-2026) & (USD Million)

Table 113. North America Antibody Drug Conjugate (ADC) Drug Revenue by Country (2016-2021) & (USD Million)

Table 114. North America Antibody Drug Conjugate (ADC) Drug Revenue by Country (2021-2026) & (USD Million)

Table 115. Europe Antibody Drug Conjugate (ADC) Drug Revenue by Type (2016-2021) & (USD Million)

Table 116. Europe Antibody Drug Conjugate (ADC) Drug Revenue by Type (2021-2026) & (USD Million)

Table 117. Europe Antibody Drug Conjugate (ADC) Drug Revenue by Application (2016-2021) & (USD Million)

Table 118. Europe Antibody Drug Conjugate (ADC) Drug Revenue by Application (2021-2026) & (USD Million)

Table 119. Europe Antibody Drug Conjugate (ADC) Drug Revenue by Country (2016-2021) & (USD Million)

Table 120. Europe Antibody Drug Conjugate (ADC) Drug Revenue by Country (2021-2026) & (USD Million)

Table 121. Asia-Pacific Antibody Drug Conjugate (ADC) Drug Revenue by Type (2016-2021) & (USD Million)

Table 122. Asia-Pacific Antibody Drug Conjugate (ADC) Drug Revenue by Type (2021-2026) & (USD Million)

Table 123. Asia-Pacific Antibody Drug Conjugate (ADC) Drug Revenue by Application (2016-2021) & (USD Million)

Table 124. Asia-Pacific Antibody Drug Conjugate (ADC) Drug Revenue by Application (2021-2026) & (USD Million)

Table 125. Asia-Pacific Antibody Drug Conjugate (ADC) Drug Revenue by Region (2016-2021) & (USD Million)

Table 126. Asia-Pacific Antibody Drug Conjugate (ADC) Drug Revenue by Region (2021-2026) & (USD Million)

Table 127. South America Antibody Drug Conjugate (ADC) Drug Revenue by Type (2016-2021) & (USD Million)

Table 128. South America Antibody Drug Conjugate (ADC) Drug Revenue by Type (2021-2026) & (USD Million)

Table 129. South America Antibody Drug Conjugate (ADC) Drug Revenue by Application (2016-2021) & (USD Million)

Table 130. South America Antibody Drug Conjugate (ADC) Drug Revenue by Application (2021-2026) & (USD Million)

Table 131. South America Antibody Drug Conjugate (ADC) Drug Revenue by Country (2016-2021) & (USD Million)

Table 132. South America Antibody Drug Conjugate (ADC) Drug Revenue by Country (2021-2026) & (USD Million)

Table 133. Middle East & Africa Antibody Drug Conjugate (ADC) Drug Revenue by Type (2016-2021) & (USD Million)

Table 134. Middle East & Africa Antibody Drug Conjugate (ADC) Drug Revenue by Type (2021-2026) & (USD Million)

Table 135. Middle East & Africa Antibody Drug Conjugate (ADC) Drug Revenue by Application (2016-2021) & (USD Million)

Table 136. Middle East & Africa Antibody Drug Conjugate (ADC) Drug Revenue by Application (2021-2026) & (USD Million)

Table 137. Middle East & Africa Antibody Drug Conjugate (ADC) Drug Revenue by Country (2016-2021) & (USD Million)

Table 138. Middle East & Africa Antibody Drug Conjugate (ADC) Drug Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Antibody Drug Conjugate (ADC) Drug Picture

Figure 2. Global Antibody Drug Conjugate (ADC) Drug Revenue Market Share by Type in 2020

Figure 3. Mmunomedics Technology

Figure 4. Immunogen Technology

Figure 5. Seattle Genetics Technology

Figure 6. Others

Figure 7. Antibody Drug Conjugate (ADC) Drug Revenue Market Share by Application in 2020

Figure 8. Biotechnology Companies Picture

Figure 9. Specialized Cancer Centers Picture

Figure 10. Biopharmaceutical Companies Picture

Figure 11. Academic Research Institutes Picture

Figure 12. Hospitals Picture

Figure 13. Others Picture

Figure 14. Global Antibody Drug Conjugate (ADC) Drug Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 15. Global Antibody Drug Conjugate (ADC) Drug Revenue and Forecast (2016-2026) & (USD Million)

Figure 16. Global Antibody Drug Conjugate (ADC) Drug Revenue Market Share by Region (2016-2026)

Figure 17. Global Antibody Drug Conjugate (ADC) Drug Revenue Market Share by Region in 2020

Figure 18. North America Antibody Drug Conjugate (ADC) Drug Revenue (USD Million) and Growth Rate (2016-2026)

Figure 19. Europe Antibody Drug Conjugate (ADC) Drug Revenue (USD Million) and Growth Rate (2016-2026)

Figure 20. Asia-Pacific Antibody Drug Conjugate (ADC) Drug Revenue (USD Million) and Growth Rate (2016-2026)

Figure 21. South America Antibody Drug Conjugate (ADC) Drug Revenue (USD Million) and Growth Rate (2016-2026)

Figure 22. Middle East and Africa Antibody Drug Conjugate (ADC) Drug Revenue (USD Million) and Growth Rate (2016-2026)

Figure 23. Antibody Drug Conjugate (ADC) Drug Market Drivers

Figure 24. Antibody Drug Conjugate (ADC) Drug Market Restraints

Figure 25. Antibody Drug Conjugate (ADC) Drug Market Trends

Figure 26. Oxford Bio Therapeutics Recent Developments and Future Plans

Figure 27. Synthon Recent Developments and Future Plans

Figure 28. Progenics Pharmaceuticals Recent Developments and Future Plans

Figure 29. Bayer HealthCare Recent Developments and Future Plans

Figure 30. Millennium Pharmaceuticals Recent Developments and Future Plans

Figure 31. Pfizer Recent Developments and Future Plans

Figure 32. Concortis Bio therapeutics Recent Developments and Future Plans

Figure 33. Roche Holding AG Recent Developments and Future Plans

Figure 34. Seattle Genetics Recent Developments and Future Plans

Figure 35. Heidelberg Pharma Recent Developments and Future Plans

Figure 36. Mersana Therapeutics Recent Developments and Future Plans

Figure 37. Astellas Pharma/Agensys Recent Developments and Future Plans

Figure 38. AbbVie Inc Recent Developments and Future Plans

Figure 39. Celldex Therapeutics Recent Developments and Future Plans

Figure 40. Immunomedics Recent Developments and Future Plans

Figure 41. Agensys Recent Developments and Future Plans

Figure 42. Genentech Recent Developments and Future Plans

Figure 43. ImmunoGen Recent Developments and Future Plans

Figure 44. Sanofi Recent Developments and Future Plans

Figure 45. Genmab Recent Developments and Future Plans

Figure 46. Amgen Recent Developments and Future Plans

Figure 47. Novartis Recent Developments and Future Plans

Figure 48. Eli Lilly Recent Developments and Future Plans

Figure 49. Global Antibody Drug Conjugate (ADC) Drug Revenue Share by Players in 2020

Figure 50. Antibody Drug Conjugate (ADC) Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 51. Global Top 3 Players Antibody Drug Conjugate (ADC) Drug Revenue Market Share in 2020

Figure 52. Global Top 10 Players Antibody Drug Conjugate (ADC) Drug Revenue Market Share in 2020

Figure 53. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 54. Global Antibody Drug Conjugate (ADC) Drug Revenue Share by Type in 2020

Figure 55. Global Antibody Drug Conjugate (ADC) Drug Market Share Forecast by Type (2021-2026)

Figure 56. Global Antibody Drug Conjugate (ADC) Drug Revenue Share by Application in 2020

Figure 57. Global Antibody Drug Conjugate (ADC) Drug Market Share Forecast by Application (2021-2026)

Figure 58. North America Antibody Drug Conjugate (ADC) Drug Sales Market Share by Type (2016-2026)

Figure 59. North America Antibody Drug Conjugate (ADC) Drug Sales Market Share by Application (2016-2026)

Figure 60. North America Antibody Drug Conjugate (ADC) Drug Revenue Market Share by Country (2016-2026)

Figure 61. United States Antibody Drug Conjugate (ADC) Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 62. Canada Antibody Drug Conjugate (ADC) Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 63. Mexico Antibody Drug Conjugate (ADC) Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 64. Europe Antibody Drug Conjugate (ADC) Drug Sales Market Share by Type (2016-2026)

Figure 65. Europe Antibody Drug Conjugate (ADC) Drug Sales Market Share by Application (2016-2026)

Figure 66. Europe Antibody Drug Conjugate (ADC) Drug Revenue Market Share by Country (2016-2026)

Figure 67. Germany Antibody Drug Conjugate (ADC) Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 68. France Antibody Drug Conjugate (ADC) Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 69. United Kingdom Antibody Drug Conjugate (ADC) Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 70. Russia Antibody Drug Conjugate (ADC) Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 71. Italy Antibody Drug Conjugate (ADC) Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 72. Asia-Pacific Antibody Drug Conjugate (ADC) Drug Sales Market Share by Type (2016-2026)

Figure 73. Asia-Pacific Antibody Drug Conjugate (ADC) Drug Sales Market Share by Application (2016-2026)

Figure 74. Asia-Pacific Antibody Drug Conjugate (ADC) Drug Revenue Market Share by Region (2016-2026)

Figure 75. China Antibody Drug Conjugate (ADC) Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 76. Japan Antibody Drug Conjugate (ADC) Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 77. South Korea Antibody Drug Conjugate (ADC) Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 78. India Antibody Drug Conjugate (ADC) Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 79. Southeast Asia Antibody Drug Conjugate (ADC) Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 80. Australia Antibody Drug Conjugate (ADC) Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 81. South America Antibody Drug Conjugate (ADC) Drug Sales Market Share by Type (2016-2026)

Figure 82. South America Antibody Drug Conjugate (ADC) Drug Sales Market Share by Application (2016-2026)

Figure 83. South America Antibody Drug Conjugate (ADC) Drug Revenue Market Share by Country (2016-2026)

Figure 84. Brazil Antibody Drug Conjugate (ADC) Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 85. Argentina Antibody Drug Conjugate (ADC) Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 86. Middle East and Africa Antibody Drug Conjugate (ADC) Drug Sales Market Share by Type (2016-2026)

Figure 87. Middle East and Africa Antibody Drug Conjugate (ADC) Drug Sales Market Share by Application (2016-2026)

Figure 88. Middle East and Africa Antibody Drug Conjugate (ADC) Drug Revenue Market Share by Country (2016-2026)

Figure 89. Turkey Antibody Drug Conjugate (ADC) Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 90. Saudi Arabia Antibody Drug Conjugate (ADC) Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 91. UAE Antibody Drug Conjugate (ADC) Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 92. Methodology

Figure 93. Research Process and Data Source